Spineweek 2008 in Geneva, Switzerland
Geneva. The Spineweek is seen as one of the most important events for professionals in the dynamic field of spinal surgery. And as every four years, members from various spine societies around the globe joined the meetings, sessions and work shops in order to share their gained experiences and knowledge in terms of the currently most discussed topics in spine.
During this exciting week Prodisc was discussed by several experts and following international study groups presented their latest results:
– | C Mehren, CJ Siepe, F Mackel, et al. CLINICAL OUTCOME AND RADIOLOGICAL ANALYSIS FOLLOWING TCDR WITH PRODISC C AT THE 24 MONTHS FOLLOW UP [read more] |
| – | RB Delamarter, J Zigler, J Goldstein 5-YEAR RESULTS OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER FDA INVESTIGATIONAL DEVICE EXEMPTION (IDE) PRODISC®-L TOTAL DISC REPLACEMENT (TDR) CLINICAL TRIAL [read more] |
| – | BV Darden, DB Murrey, JE Zigler, et al. RESULTS OF THE PROSPECTIVE, RANDOMIZED, MULTI-CENTER FOOD AND DRUG ADMINISTRATION INVESTIGATIONAL DEVICE EXEMPTION STUDY OF THE PRODISC-C TOTAL DISC REPLACEMENT VERSUS ANTERIOR DISCECTOMY AND FUSION FOR THE TREATMENT OF 1-LEVEL SYMPTOMATIC CERVICAL DISC DISEASE [read more] |
Furthermore Synthes organized a well visited Non Fusion workshop where Mr. Khai Lam gave an excellent review on the Prodisc-L system, the recommended indications and the promising results that he has been able to achieve in the last few years.
